Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Marksans Pharma Annual Report

Marksans Pharma Ltd submitted its Annual Report for FY 2025-26. The filing also includes a notice for the 34th Annual General Meeting.

Source

BSE filing, NSE: MARKSANS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Marksans Pharma Ltd: key numbers

Share price
₹315.30
Market cap
₹14,288 Cr
Revenue (annual)
₹2,951 Cr
Net profit (annual)
₹417.9 Cr
P/E (TTM)
27.6×Sector 41.3×
Promoter holding
43.87%+0.00% QoQ
FII holding
19.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Marksans Pharma Ltd

All →

Other annual report announcements

All →